194 related articles for article (PubMed ID: 26045764)
1. Cardiac hypertrophy is positively regulated by long non-coding RNA PVT1.
Yu YH; Hu ZY; Li MH; Li B; Wang ZM; Chen SL
Int J Clin Exp Pathol; 2015; 8(3):2582-9. PubMed ID: 26045764
[TBL] [Abstract][Full Text] [Related]
2. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
3. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p.
Ji H; Qu J; Peng W; Yang L
Int Heart J; 2022; 63(3):602-611. PubMed ID: 35650160
[TBL] [Abstract][Full Text] [Related]
5. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PEG10 aggravates cardiac hypertrophy through regulating HOXA9.
Wen ZQ; Li SH; Shui X; Tang LL; Zheng JR; Chen L
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):281-286. PubMed ID: 31389601
[TBL] [Abstract][Full Text] [Related]
7. Antihypertrophic Memory After Regression of Exercise-Induced Physiological Myocardial Hypertrophy Is Mediated by the Long Noncoding RNA Mhrt779.
Lin H; Zhu Y; Zheng C; Hu D; Ma S; Chen L; Wang Q; Chen Z; Xie J; Yan Y; Huang X; Liao W; Kitakaze M; Bin J; Liao Y
Circulation; 2021 Jun; 143(23):2277-2292. PubMed ID: 33757294
[TBL] [Abstract][Full Text] [Related]
8. [Aconitine ameliorates cardiomyocyte hypertrophy induced by angiotensin Ⅱ].
Wang NN; Wang J; Tan HL; Wang YG; Gao Y; Ma ZC
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1642-1647. PubMed ID: 31090329
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CHRF facilitates cardiac hypertrophy through regulating Akt3 via miR-93.
Wo Y; Guo J; Li P; Yang H; Wo J
Cardiovasc Pathol; 2018; 35():29-36. PubMed ID: 29747050
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MIAT enhances cardiac hypertrophy partly through sponging miR-150.
Zhu XH; Yuan YX; Rao SL; Wang P
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3653-60. PubMed ID: 27649667
[TBL] [Abstract][Full Text] [Related]
11. DSCAM-AS1 mediates pro-hypertrophy role of GRK2 in cardiac hypertrophy aggravation via absorbing miR-188-5p.
Chen H; Cai K
In Vitro Cell Dev Biol Anim; 2020 Apr; 56(4):286-295. PubMed ID: 32377998
[TBL] [Abstract][Full Text] [Related]
12. Silencing of circHIPK3 Inhibits Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction by Sponging miR-185-3p.
Xu X; Wang J; Wang X
Drug Des Devel Ther; 2020; 14():5699-5710. PubMed ID: 33402817
[TBL] [Abstract][Full Text] [Related]
13. [Effect of miRNA-199a on rat cardiac hypertrophy].
Xu XD; Song XW; Jing Q; Qin YW
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 May; 39(5):446-50. PubMed ID: 21781601
[TBL] [Abstract][Full Text] [Related]
14. LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII.
Shao M; Chen G; Lv F; Liu Y; Tian H; Tao R; Jiang R; Zhang W; Zhuo C
Oncotarget; 2017 Jul; 8(29):47565-47573. PubMed ID: 28548932
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W
J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075
[TBL] [Abstract][Full Text] [Related]
17. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF
Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice.
Lee KN; Lu X; Nguyen C; Feng Q; Chidiac P
J Mol Cell Cardiol; 2017 Jul; 108():194-202. PubMed ID: 28641980
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA Pvt1 modulates the pathological cardiac hypertrophy via miR-196b-mediated OSMR regulation.
Wu Q; Chen Q; Wang J; Fan D; Zhou H; Yuan Y; Shen D
Cell Signal; 2021 Oct; 86():110077. PubMed ID: 34245860
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of TRPC1 in the development of cardiac hypertrophy.
Ohba T; Watanabe H; Murakami M; Takahashi Y; Iino K; Kuromitsu S; Mori Y; Ono K; Iijima T; Ito H
J Mol Cell Cardiol; 2007 Mar; 42(3):498-507. PubMed ID: 17174323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
